Safety and Efficacy Study of SUN 131 TDS as Compared to Placebo TDS in Adult Patients With a Chalazion
Status:
Completed
Trial end date:
2016-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of SUN-131 1.5% TDS as
compared with placebo TDS in the treatment of chalazion based on the proportion of subjects
that have complete response. Complete response is defined as the absence of any significant
clinical signs of a chalazion with possible scaring or skin defects resulting from healing of
the chalazion allowed.